Whether the depression of AMPK in NASH alters MKP1-mediated MAPK signaling or whether MKP1 in response to metabolic dysfunction promotes AMPK downregulation in the NAFL to NASH transition is unclear. This evidence concerns the gene PRKAA1 and metabolic dysfunction-associated steatohepatitis.